Effects of hydrofluoroalkane formulations of ciclesonide 400 microg once daily vs fluticasone 250 microg twice daily on methacholine hyper-responsiveness in mild-to-moderate persistent asthma
about
Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and childrenAddition to inhaled corticosteroids of long-acting beta 2-agonists versus anti-leukotrienes for chronic asthmaAddition to inhaled corticosteroids of long-acting beta2-agonists versus anti-leukotrienes for chronic asthma.Ciclesonide versus placebo for chronic asthma in adults and childrenCiclesonide versus other inhaled steroids for chronic asthma in children and adultsLong-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthmaInhaled ciclesonide versus inhaled budesonide or inhaled beclomethasone or inhaled fluticasone for chronic asthma in adults: a systematic reviewCiclesonide: a safe and effective inhaled corticosteroid for the treatment of asthma.Ciclesonide for the treatment of asthma.Ciclesonide in persistent asthma: the evidence of its therapeutic value.Effect of inhaled corticosteroid particle size on asthma efficacy and safety outcomes: a systematic literature review and meta-analysis.Airway selectivity: an update of pharmacokinetic factors affecting local and systemic disposition of inhaled steroids.The newly developed inhaled corticosteroid ciclesonide for the treatment of asthma.Pharmacokinetic and pharmacodynamic properties of inhaled ciclesonide.Systematic Review: FDA-Approved Prescription Medications for Adults With Constipation.Effects of asthma treatment: the present and future.Efficacy and safety of inhaled corticosteroids relative to fluticasone propionate: a systematic review of randomized controlled trials in asthma.Methacholine challenge testing: comparative pharmacology.
P2860
Q24197682-2E1D5E75-4641-486D-B7D2-45C9112A6A2EQ24200999-250FE0FA-340E-4290-B807-1A91F3998AB5Q24234499-2A34258C-8DFA-41B4-AE41-D99486055369Q24243016-FA263AAC-BE4A-42EC-805E-1356F350F011Q24243159-30C68B27-BEEB-4ED7-9495-4559EA949670Q24244152-BBB88D52-6ACA-4B8C-BFFE-0ED6E7CF62CAQ33245730-D181F15B-A5B0-4CD4-9665-B0556F9D2EF8Q34623848-56C99321-3E13-4881-9563-6C3D6D171C2DQ35166788-6334B60F-097F-4E00-9869-8FFE25ED2F79Q35876418-653575EF-E38D-4ECE-8FC5-4468494649F1Q36273317-40860F51-5712-4FF0-9F9C-A507CF7DEBDCQ36478796-24627926-9207-4C32-8CBD-0E3D1A12B83AQ36613943-8DEFC3C7-4BE0-423D-9C01-D14B0FD9F1D6Q36782563-EF3CC475-26AC-476F-B76E-26C656C60757Q37711191-99CD1EA3-CEB0-42C0-A2A2-929F9807205BQ37755242-81979AE3-E652-4B33-B737-88B412E0FA6BQ40104404-068F6A73-0C40-4DE6-96A9-D1CF003C4BE6Q55233920-1689EDCD-4896-46A7-A5D2-E022FBC0508F
P2860
Effects of hydrofluoroalkane formulations of ciclesonide 400 microg once daily vs fluticasone 250 microg twice daily on methacholine hyper-responsiveness in mild-to-moderate persistent asthma
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Effects of hydrofluoroalkane f ...... -to-moderate persistent asthma
@ast
Effects of hydrofluoroalkane f ...... -to-moderate persistent asthma
@en
type
label
Effects of hydrofluoroalkane f ...... -to-moderate persistent asthma
@ast
Effects of hydrofluoroalkane f ...... -to-moderate persistent asthma
@en
prefLabel
Effects of hydrofluoroalkane f ...... -to-moderate persistent asthma
@ast
Effects of hydrofluoroalkane f ...... -to-moderate persistent asthma
@en
P2093
P2860
P1476
Effects of hydrofluoroalkane f ...... -to-moderate persistent asthma
@en
P2093
Brian J Lipworth
Caroline E Bates
Daniel K C Lee
Kay Haggart
P2860
P356
10.1111/J.1365-2125.2004.02108.X
P407
P50
P577
2004-07-01T00:00:00Z